Metastatic prostate cancer subtypes ‘prognostic’
Researchers have demonstrated that patients with castration-resistant disease fall into luminal and basal subtypes and these respond differently to…
Researchers have demonstrated that patients with castration-resistant disease fall into luminal and basal subtypes and these respond differently to…
Once confined to rural and remote patients, the approach has merit for any cancer diagnostic clinic, WA researchers say.
Primary care data show poor adherence to screening guidelines.
The potential danger for patients with breast or prostate cancer must not be overlooked, expert says.
The finding that only a handful of men see a radiation oncologist before prostatectomy is concerning, say Australian authors.
Post-hoc analysis of a major trial pinpoints two patient subgroups mostly likely to gain a survival benefit.
New trial results back its benefits but a leading radiologist suggests a more 'nuanced' approach will likely evolve.
Government funding of multiparametric MRI of the prostate is also increasing equity in healthcare, clinicians say.
Trial results show improved clinical outcome in a subset of men with castration-resistant disease, researchers say.
Researchers say there’s a strong association, underlining the potential benefit of vaccination for males.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.